Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections in the emergency department

Journal of Emergency Medicine

Volumn 42, Issue 4, 2012, Pages 392-399

  Walraven, Carla J ^a   Lingenfelter, Erin ^a   Rollo, Jeannie ^a   Madsen, Troy ^b   Alexander, Donald P ^a  

^a UNIVERSITY OF UTAH HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

community acquired MRSA; diagnosis; emergency department; skin and soft tissue infections; treatment

Indexed keywords

CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL EVALUATION; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE PREDISPOSITION; ELECTRONIC MEDICAL RECORD; EMERGENCY WARD; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; MULTICENTER STUDY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SINGLE DRUG DOSE; SKIN INCISION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; SURGICAL DRAINAGE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84859718441     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2011.03.009     Document Type: Article

References (18)

1. G.J. Moran, A. Krishnadasan, and R.J. Gorwitz Methicillin-resistant S. aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
2. M. Halem, J. Trent, J. Green, and F. Kerdel Community-acquired methicillin resistant Staphylococcus aureus skin infection Semin Cutan Med Surg 25 2006 68 71
3. B.C. Millar, A. Loughrey, J.S. Elborn, and J.E. Moore Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) J Hosp Infect 67 2007 109 113
4. S. Boyle-Vavra, and R.S. Daum Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin Lab Invest 87 2007 3 9
5. S.W. Fleming, L.H. Brown, and S.E. Tice Community-acquired methicillin-resistant Staphylococcus aureus infections: report of a local outbreak and implications for emergency department care J Am Acad Nurse Pract 18 2006 297 300
6. M.E. Stryjewski, and H.F. Chambers Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus Clin Infect Dis 44 2007 777 784
7. L.B. Johnson, S. Saeed, J. Pawlak, O. Manzor, and L.D. Saravolatz Clinical and laboratory features of community-associated methicillin-resistant Staphylococcus aureus: is it really new? Infect Control Hosp Epidemiol 27 2006 133 138
8. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and participants in the Centers for Disease Control and Prevention-convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the centers for disease control and prevention [2006]. Available at: http://www.cdc.gov/ncidod/ dhqp/ar-mrsa-ca.htm. Accessed April 22, 2009.
9. Centers for Disease Control and Prevention. Community-associated MRSA information for clinicians. Available at: http://www.cdc.gov/ncidod/dhqp/ar- mrsa-ca-clinicians.html. Accessed April 26, 2009.
10. Centers for Disease Control and Prevention. Outpatient management of skin and soft tissue infection in the era of community-associated MRSA. Available at: http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca-skin.html. Accessed June 10, 2009.
11. L.G. Miller, C. Quan, and A. Shay A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection Clin Infect Dis 44 2007 483 492
12. th edn. 2008 Antimicrobial Therapy, Inc. Sperryville, VA
13. M. Patel Community-associated methicillin-resistant Staphylococcus aureus infections: epidemiology, recognition, and management Drugs 69 2009 693 716
14. M.D. King, B.J. Humphrey, Y.F. Wang, E.V. Kourbatova, S.M. Ray, and H.M. Blumberg Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections Ann Intern Med 144 2006 309 317
15. M. Patel, K.B. Waites, S.A. Moser, G.A. Cloud, and C.J. Hoesley Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates J Clin Microbiol 44 2006 2481 2484
16. P.M. Rajendran, D. Young, and T. Maurer Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection Antimicrob Agents Chemother 51 2007 4044 4048
17. J.E. Fincham Response rates and responsiveness for surveys, standards, and the Journal Am J Pharm Educ 72 2008 43
18. SuperSurvey. Online survey response rates and times: background and guidance for industry. Available at: http://www.supersurvey.com/papers/ supersurvey-white-paper-response-rates.pdf. Accessed February 8, 2009.